Antioxidant Activity and Toxicity of Fullerenols via Bioluminescence Signaling: Role of Oxygen Substituents.

Ekaterina S Kovel, Anna S Sachkova, Natalia G Vnukova, Grigoriy N Churilov, Elena M Knyazeva, Nadezhda S Kudryasheva
Author Information
  1. Ekaterina S Kovel: Institute of Biophysics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia. kkovel@yandex.ru. ORCID
  2. Anna S Sachkova: National Research Tomsk Polytechnic University, 634050 Tomsk, Russia. asachkova@tpu.ru.
  3. Natalia G Vnukova: Institute of Physics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia. Nata_hd@rambler.ru.
  4. Grigoriy N Churilov: Institute of Physics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia. churilov@iph.krasn.ru.
  5. Elena M Knyazeva: National Research Tomsk Polytechnic University, 634050 Tomsk, Russia. knyazeva@tpu.ru.
  6. Nadezhda S Kudryasheva: Institute of Biophysics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia. n-qdr@yandex.ru. ORCID

Abstract

Fullerenols are nanosized water-soluble polyhydroxylated derivatives of fullerenes, a specific allotropic form of carbon, bioactive compounds, and perspective basis for drug development. Our paper analyzes the antioxidant activity and toxicity of a series of fullerenols with different number of oxygen substituents. Two groups of fullerenols were under investigation: (1) CO(OH), CO(OH), where x + y = 24-28 and (2) CO(OH), FeCO(OH), Gd@CO(OH), where x + y = 40-42. Bioluminescent cellular and enzymatic assays (luminous marine bacteria and their enzymatic reactions, respectively) were applied to monitor toxicity in the model fullerenol solutions and bioluminescence was applied as a signaling physiological parameter. The inhibiting concentrations of the fullerenols were determined, revealing the fullerenols' toxic effects. Antioxidant fullerenol' ability was studied in solutions of model oxidizer, 1,4-benzoquinone, and detoxification coefficients of general and oxidative types ( and ) were calculated. All fullerenols produced toxic effect at high concentrations (>0.01 g L), while their antioxidant activity was demonstrated at low and ultralow concentrations (<0.001 g L). Quantitative toxic and antioxidant characteristics of the fullerenols (effective concentrations, concentration ranges, , and ) were found to depend on the number of oxygen substituents. Lower toxicity and higher antioxidant activity were determined in solutions of fullerenols with fewer oxygen substituents (x + y = 24-28). The differences in fullerenol properties were attributed to their catalytic activity due to reversible electron acceptance, radical trapping, and balance of reactive oxygen species in aqueous solutions. The results provide pharmaceutical sciences with a basis for selection of carbon nanoparticles with appropriate toxic and antioxidant characteristics. Based on the results, we recommend, to reduce the toxicity of prospective endohedral gadolinium-fullerenol preparations Gd@CO(OH), decreasing the number of oxygen groups to x + y = 24-28. The potential of bioluminescence methods to compare toxic and antioxidant characteristics of carbon nanostructures were demonstrated.

Keywords

References

  1. Biochem Soc Trans. 2001 May;29(Pt 2):345-50 [PMID: 11356180]
  2. Biochem Biophys Res Commun. 2002 May 31;294(1):116-9 [PMID: 12054749]
  3. Ecotoxicol Environ Saf. 2002 Oct;53(2):221-5 [PMID: 12568457]
  4. Bull Exp Biol Med. 2003 Aug;136(2):209-11 [PMID: 14631513]
  5. Annu Rev Pharmacol Toxicol. 2004;44:239-67 [PMID: 14744246]
  6. Trends Biotechnol. 2004 Jun;22(6):295-303 [PMID: 15158059]
  7. Hum Mol Genet. 2004 Nov 1;13(21):2625-32 [PMID: 15367484]
  8. Nitric Oxide. 2004 Sep;11(2):201-7 [PMID: 15491853]
  9. J Assoc Physicians India. 2004 Oct;52:794-804 [PMID: 15909857]
  10. J Photochem Photobiol B. 2006 Apr 3;83(1):77-86 [PMID: 16413195]
  11. Photochem Photobiol Sci. 2007 Jan;6(1):35-40 [PMID: 17200734]
  12. Photochem Photobiol Sci. 2007 Jan;6(1):67-70 [PMID: 17200739]
  13. Anal Bioanal Chem. 2007 Mar;387(6):2009-16 [PMID: 17237922]
  14. J Photochem Photobiol B. 2007 Sep 25;88(2-3):131-6 [PMID: 17716903]
  15. Anal Chim Acta. 2008 Feb 4;608(1):2-29 [PMID: 18206990]
  16. Free Radic Biol Med. 2009 Sep 15;47(6):786-93 [PMID: 19539750]
  17. Toxicol Appl Pharmacol. 2010 Feb 15;243(1):27-34 [PMID: 19914272]
  18. Circ Res. 2010 Oct 29;107(9):1058-70 [PMID: 21030723]
  19. Environ Toxicol Chem. 2011 May;30(5):1013-7 [PMID: 21309025]
  20. Anal Bioanal Chem. 2011 Apr;400(2):343-51 [PMID: 21336798]
  21. J Environ Radioact. 2011 Apr;102(4):407-11 [PMID: 21388726]
  22. Med Sci Monit. 2012 Feb;18(2):BR76-83 [PMID: 22293870]
  23. J Am Chem Soc. 2012 Jun 13;134(23):9762-7 [PMID: 22591414]
  24. J Hazard Mater. 2012 Jul 30;225-226:114-23 [PMID: 22626628]
  25. Integr Biol (Camb). 2013 Jan;5(1):43-7 [PMID: 22961501]
  26. J Photochem Photobiol B. 2012 Dec 5;117:164-70 [PMID: 23123596]
  27. Environ Monit Assess. 2013 Jul;185(7):5909-16 [PMID: 23151839]
  28. J Alzheimers Dis. 2013;34(1):115-31 [PMID: 23364141]
  29. J Environ Radioact. 2013 Jun;120:19-25 [PMID: 23410594]
  30. Curr Cardiovasc Imaging Rep. 2013 Feb 1;6(1):61-68 [PMID: 23504765]
  31. Arch Toxicol. 2013 Jul;87(7):1157-80 [PMID: 23543009]
  32. Biochim Biophys Acta. 2013 Sep;1828(9):2007-14 [PMID: 23702461]
  33. Methods Mol Biol. 2013;1028:75-100 [PMID: 23740114]
  34. Mol Neurobiol. 2014 Apr;49(2):771-83 [PMID: 24085563]
  35. Biomed Res Int. 2013;2013:751913 [PMID: 24222914]
  36. Environ Sci Pollut Res Int. 2015 Jan;22(1):155-67 [PMID: 25146119]
  37. Radiology. 2015 Jun;275(3):803-9 [PMID: 25633504]
  38. Environ Monit Assess. 2015 Mar;187(3):89 [PMID: 25663400]
  39. Electromagn Biol Med. 2015;34(2):160-6 [PMID: 26098530]
  40. Comb Chem High Throughput Screen. 2015;18(10):952-9 [PMID: 26377542]
  41. Beilstein J Org Chem. 2015 Aug 11;11:1398-411 [PMID: 26425195]
  42. Biochemistry (Mosc). 2015 Jun;80(6):733-44 [PMID: 26531018]
  43. Luminescence. 2016 Sep;31(6):1283-9 [PMID: 26864478]
  44. Chem Rev. 2016 Mar 9;116(5):3029-85 [PMID: 26875845]
  45. Dalton Trans. 2016 Jun 7;45(21):8696-9 [PMID: 27064096]
  46. Photochem Photobiol. 2017 Mar;93(2):536-540 [PMID: 27645453]
  47. J Med Chem. 2017 Apr 27;60(8):3221-3240 [PMID: 28135088]
  48. Sci Adv. 2017 Aug 02;3(8):e1603229 [PMID: 28782034]
  49. Biochem Biophys Rep. 2016 Nov 09;9:1-8 [PMID: 28955983]
  50. Int J Mol Sci. 2018 Mar 10;19(3):null [PMID: 29534471]
  51. Circ Res. 2018 Mar 16;122(6):877-902 [PMID: 29700084]
  52. Sci Total Environ. 2018 Jun 1;626:1295-1309 [PMID: 29898537]
  53. J Adv Res. 2018 Jun 01;14:73-79 [PMID: 30023134]
  54. ISA Trans. 1981;20(1):29-33 [PMID: 7251338]

Grants

  1. project 0356-2017-0017/the state budget allocated to the fundamental research at the Russian Academy of Sciences
  2. CE Program/Tomsk Polytechnic University
  3. Program: 'Nanostructures: physics, chemistry, biology, technological basis'/PRAN-32
  4. 18-29-19003/RFBR
  5. 18-44-242002/RFBR-Krasnoyarsk Regional Foundation
  6. 18-44-240004/RFBR-Krasnoyarsk Regional Foundation

MeSH Term

Antioxidants
Biological Assay
Fullerenes
Inactivation, Metabolic
Kinetics
Luminescence
Luminescent Measurements
Luminol
Oxygen
Reactive Oxygen Species
Solutions

Chemicals

Antioxidants
Fullerenes
Reactive Oxygen Species
Solutions
fullerenol
Luminol
Oxygen

Word Cloud

Created with Highcharts 10.0.0antioxidantfullerenolsoxygenOHactivitytoxicitytoxicx+y=solutionsconcentrationscarbonnumbersubstituentsCO24-28fullerenolbioluminescencecharacteristicsFullerenolsbioactivebasisgroups1Gd@COenzymaticappliedmodeldeterminedAntioxidantgLdemonstratedreactivespeciesresultsnanosizedwater-solublepolyhydroxylatedderivativesfullerenesspecificallotropicformcompoundsperspectivedrugdevelopmentpaperanalyzesseriesdifferentTwoinvestigation:2FeCO40-42Bioluminescentcellularassaysluminousmarinebacteriareactionsrespectivelymonitorsignalingphysiologicalparameterinhibitingrevealingfullerenols'effectsfullerenol'abilitystudiedoxidizer4-benzoquinonedetoxificationcoefficientsgeneraloxidativetypescalculatedproducedeffecthigh>001lowultralow<0001QuantitativeeffectiveconcentrationrangesfounddependLowerhigherfewerdifferencespropertiesattributedcatalyticduereversibleelectronacceptanceradicaltrappingbalanceaqueousprovidepharmaceuticalsciencesselectionnanoparticlesappropriateBasedrecommendreduceprospectiveendohedralgadolinium-fullerenolpreparationsdecreasingpotentialmethodscomparenanostructuresActivityToxicityviaBioluminescenceSignaling:RoleOxygenSubstituentscompoundbioassay

Similar Articles

Cited By